benign

Quick, Affordable, Online, Engaging CME Activities
Approved for AMA PRA Category I Credit(s)™
Accessible with any internet enabled device. (Computer, Tablet, or Smart Phone, TV, etc.)
1 year UNLIMITED access.
Purchase individually, or save money by selecting a Volume. (Volume = 10 AMA PRA Category 1 Credits™)
Immediate CME Certificate upon completion.
Interactive Format via: Videos, Images, Case Studies, Quizzes and more.
Complete a Volume of CME Vitals a year and stay up-to-date with your triennium requirement.
Consistently releasing new CME Vitals.
Have a group? Save more with group discount pricing. Call (727) 363-4500 for details.

Quick, Affordable, Online, Engaging CME Activities
Approved for AMA PRA Category I Credit(s)™
Accessible with any internet enabled device. (Computer, Tablet, or Smart Phone, TV, etc.)
1 year UNLIMITED access.
Purchase individually, or save money by selecting a Volume. (Volume = 10 AMA PRA Category 1 Credits™)
Immediate CME Certificate upon completion.
Interactive Format via: Videos, Images, Case Studies, Quizzes and more.
Complete a Volume of CME Vitals a year and stay up-to-date with your triennium requirement.
Consistently releasing new CME Vitals.
Have a group? Save more with group discount pricing. Call (727) 363-4500 for details.

2021 Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum – A CME Teaching Activity

Release Date

02/15/21

AMA PRA Category 1 Credit(s)™:
10.25
Category A CE Credits:

About This CME Teaching Activity

This continuing education activity reviews best practices in the growing field of radiotheragnostics (aka theranostics or theragnostics) for benign and malignant diseases, beginning with the fundamentals and extending to include advanced clinical applications. A review of historically established therapies that have been optimally modernized as well as the recently introduced state-of-the-art modalities are included. The expert faculty discuss the optimization of the radiotheragnostic practices for best utilization of various radiopharmaceuticals in contemporary health care delivery systems, both academic and private practice settings.